Antioxidant therapy for AIDS

European Journal of Clinical Investigation

Volumn 30, Issue 10, 2000, Pages 841-843

  Staal, F ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; GLUTATHIONE; PLACEBO; REACTIVE OXYGEN METABOLITE; THIOREDOXIN; UBIQUINONE; VIRUS RNA;

CELL PROTECTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA SYNTHESIS; DOUBLE BLIND PROCEDURE; DRUG BIOAVAILABILITY; GLUTATHIONE METABOLISM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; NATURAL KILLER CELL; NOTE; OXIDATION REDUCTION POTENTIAL; OXIDATIVE STRESS; PRIORITY JOURNAL; VIRUS INHIBITION; VIRUS LOAD;

EID: 0033784054     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2000.00728.x     Document Type: Note

References (21)

1. Low concentrations of acid-soluble thiol (cysteine) in the blood plasma of HIV-1-infected patients
2. Intracellular glutathione levels in T cell subsets decrease in HIV-infected individuals
3. Glutathione deficiency and human immunodeficiency virus infection
4. Role of cysteine and glutathione in HIV infection and other diseases associated with muscle wasting and immunological dysfunction
5. Plasma glutathione concentrations in children infected with human immunodeficiency virus
6. Serum selenium, plasma glutathione (GSH) and erythrocyte glutathione peroxidase (GSH-Px) levels in asymptomatic versus symptomatic human immunodeficiency virus-1 (HIV-1) -infection
7. Oxidative stress and thiol depletion in plasma and peripheral blood lymphocytes from HIV-infected patients: Toxicological and pathological implications
8. Erythrocyte glutathione deficiency in symptom-free HIV infection is associated with decreased synthesis rate
9. Systemic glutathione deficiency in symptom-free HIV-seropositive individuals
10. Massive loss of sulfur in HIV infection
11. Cytokine-stimulated human immunodeficiency virus replication is inhibited by N-acetyl-L-cysteine
12. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1
13. Intracellular thiols regulate activation of nuclear factor kappa B and transcription of human immunodeficiency virus
14. Effect of N-acetylcysteine (NAC) treatment on HIV-1 infection: A double-blind placebo-controlled trial
15. Improvement of immune functions in HIV infection by sulfur supplementation: Two randomized trials
16. N-acetylcysteine (NAC) replenishes glutathione in HIV infection
17. Virological and immunological effects of antioxidant treatment in patients with HIV infection
18. Safety, pharmacokenetics, and antiviral activity of N-acetylcysteine in HIV-infected individuals
19. A randomized trial of N-acetylcysteine for prevention of trimethoprim-sulfamethoxazole hypersensitivity reactions in Pneumocystis carinii pneumonia prophylaxis (CTN 057). Canadian HIV Trials Network 057 Study Group
20. Supplementation of N-acetylcysteine fails to increase glutathione in lymphocytes and plasma of patients with AIDS
21. Sodium selenite and N-acetylcysteine in antiretroviral-naive HIV-1-infected patients: A randomized, controlled pilot study